Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype.
Saved in:
| Title: | Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype. |
|---|---|
| Authors: | Angius A; Institute of Genetic and Biomedical Research (IRGB), CNR, Cittadella Universitaria di Cagliari, 09042 Monserrato, Italy., Cossu-Rocca P; Department of Medical, Surgical and Experimental Sciences, University of Sassari, Via P. Manzella, 4, 07100 Sassari, Italy.; Department of Diagnostic Services, 'Giovanni Paolo II' Hospital, ASSL Olbia-ATS Sardegna, 07026 Olbia, Italy., Arru C; Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy., Muroni MR; Department of Medical, Surgical and Experimental Sciences, University of Sassari, Via P. Manzella, 4, 07100 Sassari, Italy., Rallo V; Institute of Genetic and Biomedical Research (IRGB), CNR, Cittadella Universitaria di Cagliari, 09042 Monserrato, Italy.; Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy., Carru C; Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy., Uva P; CRS4, Science and Technology Park Polaris, Piscina Manna, 09010 Pula, CA, Italy., Pira G; Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy., Orrù S; Department of Pathology, 'A. Businco' Oncologic Hospital, ASL Cagliari, 09121 Cagliari, Italy., De Miglio MR; Institute of Genetic and Biomedical Research (IRGB), CNR, Cittadella Universitaria di Cagliari, 09042 Monserrato, Italy. |
| Source: | Cancers [Cancers (Basel)] 2020 Nov 07; Vol. 12 (11). Date of Electronic Publication: 2020 Nov 07. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
